![Vassiliki Economides](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vassiliki Economides
Director/Board Member at
Altum Pharmaceuticals, Inc.
Profile
Vassiliki Celia Economides is currently Director at MedMelior, Inc. Former positions include Chief Financial Officer & Executive Vice President at Nexoplex Bio, Inc. from 2021 to 2024, Senior Vice President-Strategy & External Affairs at Kezar Life Sciences, Inc., Vice President-Corporate & Public Affairs at Aurinia Pharmaceuticals, Inc. from 2016 to 2019, Director-Global Medical Affairs at BioMarin Pharmaceutical, Inc. from 2015 to 2016, Senior Director-IR & Corporate Communications at Prosensa Holding NV, and Director-Investor Relations & Program Development at Biotechnology Innovation Organization.
Education includes a graduate degree from The Trustees of Columbia University in The City of New York in 2004 and an undergraduate degree from McGill University in 2001.
Vassiliki Economides active positions
| Companies | Position | Start |
|---|---|---|
Altum Pharmaceuticals, Inc.
 Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Engage in business of developing therapeutics for women | Director/Board Member | - |
Former positions of Vassiliki Economides
| Companies | Position | End |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Investor Relations Contact | 01/03/2019 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/06/2016 |
| GRITSTONE BIO, INC. | Chief Executive Officer | - |
| KEZAR LIFE SCIENCES, INC. | Investor Relations Contact | - |
| PROSENSA HOLDING NV | Investor Relations Contact | - |
Training of Vassiliki Economides
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
93
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Engage in business of developing therapeutics for women | Health Technology |
- Stock Market
- Insiders
- Vassiliki Economides
